Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

182.56 +33.77 (+22.70%)
Streaming Delayed Price Updated: 3:57 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
23 24 Next >
News headline image
Axsome Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
Axsome Therapeutics (AXSM) Q4 2022 Earnings Call Transcript ↗
AXSM earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
Why Axsome Therapeutics (AXSM) Shares Are Trading Higher ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher by 3.22% to $63.02 Monday morning after the company reported mixed fourth-quarter financial results. What Happened? 
Via Benzinga
News headline image
Axsome Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
Axsome Therapeutics's Earnings: A Preview ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Axsome Therapeutics ↗
 
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $1,900 Today ↗
 
Via Benzinga
News headline image
A New Bull Market Is in Sight: 3 Stocks to Buy Sooner Rather Than Later ↗
All three of these stocks have impressive growth prospects. 
Via The Motley Fool
News headline image
Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Long Term Investor Alert: Lawsuit Against Directors Filed ↗
San Diego, CA -- (SBWIRE) -- 02/17/2023 -- An investor in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) filed a lawsuit against certain directors of Axsome Therapeutics, Inc. over alleged breaches... 
Via SBWire
News headline image
Meta Platforms Layoffs 2023: What to Know as Facebook Preps More Job Cuts ↗
Meta Platforms (META) layoffs are a hot topic among traders Monday as the Facebook parent company reportedly considering more job cuts. 
Via InvestorPlace
News headline image
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug ↗
Axsome Therapeutics (AXSM) stock is taking a beating on Monday as rival Teva Pharmaceutical (TEVA) prepares a generic depression drug. 
Via InvestorPlace
News headline image
Earnings Scheduled For February 27, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
News headline image
Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling ↗
The company only just gained approval for its depression drug in August. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
2 Biotech Stocks You Can Buy and Hold for the Next Decade ↗
These companies could grow in prominence in the coming years. 
Via The Motley Fool
News headline image
3 Surefire Growth Stocks You Can Buy Right Now ↗
Maybe there's no such thing as a sure thing. But these stocks could come close. 
Via The Motley Fool
News headline image
3 Stocks That Could Soar Whether There's a New Bull Market or Not ↗
These stocks could enjoy their own bull markets regardless of what the overall market does. 
Via The Motley Fool
News headline image
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET 
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
The Ultimate Growth Stocks to Buy With $300 Right Now ↗
These three companies should deliver inflation-busting long-term growth. 
Via The Motley Fool
News headline image
2 Promising New Growth Stocks to Watch in 2023 ↗
These stocks have plenty of room to run. 
Via The Motley Fool
News headline image
3 Unstoppable Stocks to Keep Buying in 2023 ↗
These companies have what it takes to drive long-term share performance. 
Via The Motley Fool
News headline image
2 Stocks That Could Double Your Money in 2023 ↗
These biotechs could crush the market, but there is more to the story. 
Via The Motley Fool
News headline image
These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy. ↗
These stocks look cheap if you take a long-term view. 
Via The Motley Fool
News headline image
5 Top Stocks to Buy to Start the New Year Right ↗
This may be the easiest of your New Year's resolutions. And it could pay off big. 
Via The Motley Fool
News headline image
How Is The Market Feeling About Axsome Therapeutics? ↗
Axsome Therapeutics's (NASDAQ:AXSM) short percent of float has fallen 7.06% since its last report. The company recently reported that it has 7.37 million shares sold short, which is 20.81% of all... 
Via Benzinga
News headline image
100 Best Stocks Of 2022: Fossil Fuel Ignites, Solar Shines, Meds Make Miracles ↗
Energy and medical plays top the 100 Best Stocks of 2022. It makes sense, given world events that shifted the first-quarter playing field. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗
 
Via Benzinga
News headline image
2 Growth Stocks to Buy Heading Into 2023 ↗
These biotechs are far from having achieved their full potential. 
Via The Motley Fool
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.